625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I

Trial in progress A phase I ib dose finding study of ropeginterferon alfa 2b P1101 in patients with cutaneous T cell lymphoma CTCL

Efficacy and safety of duvelisib combined with chidamide as first line treatment for angioimmunoblastic T cell lymphoma AITL

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T cell lymphoma A multicenter non interventional ambispective cohort real world study

GATA 3 identifies a distinct subset of T cell prolymphocytic leukemia T PLL and is associated with CCR4 expression

Evaluation of treatment responses to methotrexate and cyclophosphamide among T LGL patients with and without Y640F and D661Y STAT3 mutations – a retrospective observational study

A Phase 2 multicenter open label single arm study assessing a 4 weekly dosing schedule for mogamulizumab in patients with mycosis fungoides Sezary syndrome MOGA 2MG Q4W

Upregulation of extracellular matrix remodeling gene set drives progression and poor prognosis in angioimmunoblastic T cell lymphoma

Contemporary survival trends in patients with adult T cell leukemia lymphoma ATLL in the United States Insights from the national cancer database

Diagnostic and therapeutic patterns in cutaneous T cell lymphomas CTCL Real world data from the lymphoma epidemiology outcome molecular epidemiology resource LEO MER prospective cohort study

Allogeneic stem cell transplant for T prolymphocytic leukemia A single center analysis

Integrated analysis of mogamulizumab trials for mature T cell lymphomas investigating differences in longitudinal effects between responders and non responders

Health related quality of life HRQoL in real world patients with cutaneous T cell lymphoma CTCL Evaluation of patient reported outcomes using the Skindex 16 in a multidisciplinary CTCL clinic

Outcomes of relapsed or refractory mature T NK cell lymphomas in the era of novel agents A nationwide observational Study in Japan

Chidamide in combination with azacitidine mitoxantrone liposomes and prednisone CAMP regimen for treatment naïve TFH derived peripheral T cell lymphoma

The charlson comorbidity index as a predictor of survival in peripheral T cell lymphoma A multicenter analysis from the gifu hematology study group

Azacytidine combined with CHOP regimen for the treatment of newly diagnosed angioimmunoblastic T cell lymphoma

Determinants of survival in primary cutaneous CD4 small-to medium-sized pleomorphic t-cell lymphoproliferative disorder PC4SMPTCL Analysis of a real world pooled database

Determinants of survival in t cell large granular lymphocytic leukemia T LGL Analysis of a real world pooled database

Outcomes in octo and nonagenarians treated with mogamulizumab based regimens for cutaneous T cell lymphoma